Skip to main content

Table 5 Baseline characteristics of the patients

From: Magnetic resonance enterography changes after antibody to tumor necrosis factor (anti-TNF) alpha therapy in Crohn’s disease: correlation with SES-CD and clinical-biological markers

Patients n = 27

 

M/F

18/9

Age at diagnosis [median]

27,4

Disease duration [years, mean (SD)]

6,1 (2,2)

Disease location

 

 -Rectum

0

 -Sigmoid/Left colon

9

 -Transverse colon

3

 -Right colon

3

 -Ileum

27

Anti-TNF drugs

 

 -IFX

18

 -ADA

9